Giovanni Porta Selected Research

Giovanni Porta Research Topics

Disease

7	Neoplasms (Cancer) 04/2024 - 03/2005
3	Inflammation (Inflammations) 07/2022 - 01/2020
2	Glioma (Gliomas) 04/2024 - 01/2011
2	Shwachman-Diamond Syndrome 10/2023 - 03/2007
2	COVID-19 09/2023 - 01/2021
2	Retinal Perforations 01/2022 - 03/2017
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2014 - 09/2009
2	Carcinogenesis 08/2013 - 03/2005
1	Glioblastoma (Glioblastoma Multiforme) 04/2024
1	Colorectal Neoplasms (Colorectal Cancer) 02/2024
1	Chronic Granulomatous Disease 11/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2023
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 10/2023
1	Pneumothorax 09/2023
1	Philadelphia Chromosome 01/2023
1	Genetic Translocation (Chromosomal Translocation) 01/2023
1	Ovarian Neoplasms (Ovarian Cancer) 08/2022
1	Metabolic Bone Diseases (Osteopenia) 07/2022
1	Osteoporosis 07/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2022
1	Necrosis 01/2022
1	Retinal Diseases 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	De Lange Syndrome (Cornelia De Lange Syndrome) 11/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Heart Failure 01/2021
1	Colitis 01/2020
1	Carcinoma (Carcinomatosis) 02/2019
1	Adenocarcinoma 01/2019
1	Olfactory Esthesioneuroblastoma (Esthesioneuroblastoma) 01/2019
1	Pulmonary Edema 01/2018
1	Reperfusion Injury 04/2017
1	Ischemia 04/2017
1	Diabetes Mellitus 04/2015
1	Proliferative Vitreoretinopathy 01/2013
1	Breast Neoplasms (Breast Cancer) 01/2009

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 04/2024 - 08/2013
4	Messenger RNA (mRNA)IBA 04/2021 - 09/2009
3	Ribonucleases (Ribonuclease)IBA 08/2023 - 02/2019
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 03/2007
3	Retinaldehyde (Retinal)IBA 01/2022 - 03/2017
2	CohesinsIBA 02/2024 - 11/2021
2	ChromatinIBA 11/2021 - 03/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2013
2	Homeodomain Proteins (Proteins, Homeobox)IBA 01/2020 - 04/2017
2	Imatinib Mesylate (Gleevec)FDA Link 01/2014 - 09/2009
1	Bevacizumab (Avastin)FDA Link 02/2024
1	atalurenIBA 10/2023
1	Indicators and Reagents (Reagents)IBA 09/2023
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2023
1	SaponinsIBA 07/2022
1	Vitamin D FDA LinkGeneric 07/2022
1	CalciumIBA 07/2022
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2022
1	Interleukin-8 (Interleukin 8)IBA 01/2022
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	CytokinesIBA 04/2021
1	cobaltous chloride (cobalt(II)chloride)IBA 01/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	Benzene (Benzole)IBA 01/2020
1	2,4-dinitrofluorobenzene sulfonic acidIBA 01/2020
1	AcidsIBA 01/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2017
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 04/2017
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2015
1	TOR Serine-Threonine KinasesIBA 08/2013
1	Phosphotransferases (Kinase)IBA 08/2013
1	Protein Isoforms (Isoforms)IBA 01/2011
1	HeterochromatinIBA 01/2009
1	RNA (Ribonucleic Acid)IBA 01/2009

Therapy/Procedure

4	Therapeutics 08/2023 - 01/2014
2	Immunotherapy 04/2024 - 08/2022
1	Drug Therapy (Chemotherapy) 04/2024
1	Hematopoietic Stem Cell Transplantation 11/2023
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 09/2023
1	Vitrectomy 01/2022
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Noninvasive Ventilation 01/2018
1	Continuous Positive Airway Pressure 01/2018